Glioblastoma trials in Norway

In Norway 8 Also abroad 424

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
Study to evaluate the therapeutic effect of a cell based immune therapy targeting cancer stem cells i the malignant brain tumor glioblastoma.
Where
Oslo
Age
18 years and over
People
60
Run by
Oslo University Hospital HF
See details and how to joinNCT03548571 · EU 2024-518663-35-00
Phase 3Taking people
Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated glioblastoma (IDHwt) patients +/- tumor treating fields (Optune)
Where
Bergen, Graalum, Kristiansand S, Oslo, Stavanger, Tromsoe, Trondheim
Age
18 years and over
People
200 worldwide
Run by
Vaestra Goetalandsregionen
See details and how to join2023-506998-35-00 · EU 2023-506998-35-00
Phase 1/2Taking people
Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
Where
Bergen, Oslo, Tromsoe, Trondheim
Age
18 years and over
People
63
Run by
Haukeland University Hospital
See details and how to joinNCT03643549 · EU 2024-515142-16-00
Phase 3Taking people
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Where
Oslo, Trondheim
Age
18 years and over
People
411 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT05904119 · EU 2023-505267-36-00
Phase 1Taking people
A study to investigate how a single dose of the drug melflufen reaches brain tumor tissue, and how it affects the tumour, in patients who are already scheduled for surgery for a returning glioblastoma
Where
Oslo
Age
18 years and over
People
10
Run by
Oncopeptides AB
See details and how to join2026-525543-32-00 · EU 2026-525543-32-00
Phase 1/2Not yet taking people in Norway
The ALPINE trial: a phase 1-2 study of intra-arterial [177Lu]Lu-PSMA-I&T for progressive or recurrent intracranial adult type diffuse glioma
Where
Trondheim
Age
18 years to 64 years
People
28 worldwide
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504696-24-00 · EU 2023-504696-24-00
Phase 3Taking people
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Where
Bergen, Kristiansand, Oslo, Stavanger, Trondheim
Age
18 years to 70 years
People
200 worldwide
Run by
Vastra Gotaland Region
See details and how to joinNCT06419946
Phase 1Taking people
Individualized Systems Medicine strategy to target cancer stem cells in patients with recurrent Glioblastoma (ISM-GBM)
Where
Oslo
Age
18 years and over
People
15
Run by
Oslo University Hospital HF
See details and how to joinNCT05043701 · EU 2023-510214-11-00